2017-18 HSC Section 3 Green Book

Hsueh et al

administration of subcutaneous heparin: overview of results of randomized trials in general, orthopedic, and urologic surgery. N Engl J Med . 1988;318:1162-1173. 30. Baron TH, Kamath PS, McBane RD. Management of antith- rombotic therapy in patients undergoing invasive procedures. N Engl J Med . 2013;368:2113-2124. 31. Amedee RG, Dhurandhar NR. Fine-needle aspiration biopsy. Laryngoscope . 2001;111:1551-1557. 32. Kumar R, Gupta R, Khullar S, Dasan B, Malhotra A. Thyroid hemangioma: a case report with a review of the literature. Clin Nucl Med . 2000;25:769-771. 33. Noordzij JP, Goto MM. Airway compromise caused by hema- toma after thyroid fine-needle aspiration. Am J Otolaryngol . 2005;26:398-399. 34. Roh JL. Intrathyroid hemorrhage and acute upper airway obstruction after fine needle aspiration of the thyroid gland. Laryngoscope . 2006;116:154-156. 35. Gauger PG, Guinea AI, Reeve TS, Delbridge LW. The spec- trum of emergency admissions for thyroidectomy. Am J Emerg Med . 1999;17:591-593. 36. Sulica L, Rosen CA, Postma GN, et al. Current practice in injection augmentation of the vocal folds: indications, treat- ment principles, techniques, and complications. Laryngoscope . 2010;120:319-325. 37. May M, Levine HL, Mester SJ, Schaitkin B. Complications of endoscopic sinus surgery: analysis of 2108 patients—incidence and prevention. Laryngoscope . 1994;104:1080-1083. 38. Ramakrishnan VR, Kingdom TT, Nayak JV, Hwang PH, Orlandi RR. Nationwide incidence of major complications in endoscopic sinus surgery. Int Forum Allergy Rhinol . 2012;2:34-39. 39. Wigand ME, Hosemann WG. Results of endoscopic surgery of the paranasal sinuses and anterior skull base. J Otolaryngol . 1991;20:385-390. 40. Nguyen QA, Cua DJ, Ng M, Rice DH. Safety of endoscopic sinus surgery in a residency training program. Ear Nose Throat J . 1999;78:898-902, 904. 41. Stankiewicz JA, Lal D, Connor M, Welch M. Complications in endoscopic sinus surgery for chronic rhinosinusitis: a 25- year experience. Laryngoscope . 2011;121:2684-2701. 42. Matthews BL, Smith LE, Jones R, Miller C, Brookschmidt JK. Endoscopic sinus surgery: outcome in 155 cases. Otolaryngol Head Neck Surg . 1991;104:244-246. 43. Vleming M, Middelweerd RJ, de Vries N. Complications of endoscopic sinus surgery. Arch Otolaryngol Head Neck Surg . 1992;118:617-623. 44. Black PM, Zervas NT, Candia GL. Incidence and management of complications of transsphenoidal operation for pituitary ade- nomas. Neurosurgery . 1987;20:920-924. 45. Ciric I, Ragin A, Baumgartner C, Pierce D. Complications of transsphenoidal surgery: results of a national survey, review of the literature, and personal experience. Neurosurgery . 1997;40: 225-236. 46. Sudhakar N, Ray A, Vafidis JA. Complications after trans- sphenoidal surgery: our experience and a review of the litera- ture. Br J Neurosurg . 2004;18:507-512. 47. Cappabianca P, Cavallo LM, Colao A, de Divitiis E. Surgical complications associated with the endoscopic endonasal

thrombosis, 9th ed. American College of Chest Physicians evidence-based clinical practice guidelines. Chest . 2012; 141(2):e419S-e494S. 16. Douketis JD, Foster GA, Crowther MA, Prins MH, Ginsberg JS. Clinical risk factors and timing of recurrent venous throm- boembolism during the initial 3 months of anticoagulant ther- apy. Arch Intern Med . 2000;160:3431-3436. 17. Kearon C, Hirsh J. Perioperative management of patients receiving oral anticoagulants. Arch Intern Med . 2003;163: 2532-2533. 18. Levine MN, Hirsh J, Gent M, et al. Optimal duration of oral anticoagulant therapy: a randomized trial comparing four weeks with three months of warfarin in patients with proximal deep vein thrombosis. Thromb Haemost . 1995;74:606-611. 19. Research Committee of the British Thoracic Society. Optimum duration of anticoagulation for deep-vein thrombosis and pul- monary embolism. Lancet . 1992;340:873-876. 20. Grines CL, Bonow RO, Casey DE Jr, et al. Prevention of pre- mature discontinuation of dual antiplatelet therapy in patients with coronary artery stents: a science advisory from the American Heart Association, American College of Cardiology, Society for Cardiovascular Angiography and Interventions, American College of Surgeons, and American Dental Association, with representation from the American College of Physicians. J Am Coll Cardiol . 2007;49:734-739. 21. King SB 3rd, Smith SC Jr, Hirshfeld JW Jr, et al. 2007 focused update of the ACC/AHA/SCAI 2005 guideline update for percutaneous coronary intervention: a report of the American College of Cardiology/American Heart Association Task Force on Practice guidelines. J Am Coll Cardiol . 2008; 51:172-209. 22. Spertus JA, Kettelkamp R, Vance C, et al. Prevalence, predic- tors, and outcomes of premature discontinuation of thienopyri- dine therapy after drug-eluting stent placement: results from the PREMIER registry. Circulation . 2006;113:2803-2809. 23. Pfisterer M, Brunner-La Rocca HP, Buser PT, et al. Late clinical events after clopidogrel discontinuation may limit the benefit of drug-eluting stents: an observational study of drug-eluting versus bare-metal stents. J Am Coll Cardiol . 2006;48:2584-2591. 24. Eisenstein EL, Anstrom KJ, Kong DF, et al. Clopidogrel use and long-term clinical outcomes after drug-eluting stent implantation. JAMA . 2007;297:159-168. 25. Torn M, Rosendaal FR. Oral anticoagulation in surgical proce- dures: risks and recommendations. Br J Haematol . 2003;123: 676-682. 26. Nieuwenhuis HK, Albada J, Banga JD, Sixma JJ. Identification of risk factors for bleeding during treatment of acute venous thromboembolism with heparin or low molecular weight heparin. Blood . 1991;78:2337-2343. 27. Levine MN, Raskob G, Landefeld S, Hirsh J. Hemorrhagic complications of anticoagulant treatment. Chest . 1995;108(4): 276S-290S. 28. Spyropoulos AC, Douketis JD. How I treat anticoagulated patients undergoing an elective procedure or surgery. Blood . 2012;120:2954-2962. 29. Collins R, Scrimgeour A, Yusuf S, Peto R. Reduction in fatal pulmonary embolism and venous thrombosis by perioperative

191